After parting ways with its diabetes franchise nearly three years ago, BD is slimming down even further with a plan to divest ...

Monitoring respiratory motion during diagnostic imaging and radiation therapy is crucial for accurate diagnosis and treatment ...

(This Feb. 5 story has been refiled to correct the name of the unit to biosciences and diagnostic solutions, from life sciences, in the headline and paragraphs 1 and 4) (Reuters) - Becton Dickinson ...

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...

Similarly, when medical device manufacturers require automated assembly systems for complex applications, they, too, turn to ...

David Schnur Associates will represent TekniPlex Interventional Devices in most of North America, Latin America, Europe, ...

Regulatory approval follows FemaSeed U.S. FDA-clearance announced September 2023 and EU CE mark approval announced June ...

BD plans to separate its Biosciences and Diagnostic Solutions unit into an independent company by fiscal 2026.

Global medical device market will reach $882.3 billion by 2032, growing by 5.5% annually over 2022-2032 owing to aging population worldwide, the prevalence of infectious diseases as well as the ...

North America medical device market is projected to grow by 3.9% annually in the forecast period and reach $ 282.3 billion by 2032, driven by the prevalence of infectious diseases as well as the ...